At the end of January 2023, the Prescription Medicines Code of Practice Authority (PMCPA) issued its first published guidance on social...
Freshfields Risk & Compliance
Europe has of late been simultaneously dealing with vaccination campaigns, the Delta wave, sun-seeking holidaymakers and a major...
It is no secret that the terms used in the EU Product Liability Directive 85/374/EEC (PLD) leave a lot of room for interpretation. A...
It would be uncharitable (but sometimes accurate) to suggest that reading patent judgments is a good cure for insomnia. Something that...
To protect the health of their people during the COVID-19 outbreak, many countries have imposed trade restrictions, such as export bans,...
The first judicial decision made under Canada's regulations on certificates of supplementary protection (CSPs) highlights some...
Pharmaceutical companies are working around the clock towards a common aim: diagnosing, treating and preventing infections from COVID-19....
When does a pharmaceutical company’s granted patent prevent the entry of a generic competitor? The answer is, frequently, grey. Through...
The UK Supreme Court handed down its second patent decision in 6 months today. The judgment in Actavis Group & ors v ICOS Corporation &...
In an decision issued on Wednesday 21 June (Case C-621/15 - N.W, L.W, C.W v Sanofi Pasteur MSD SNC), the ECJ has attempted to grapple, in...
Health Secretary Jeremy Hunt was unequivocal when he told the House of Commons Health Committee at a 24 January oral evidence session for...